martes, 22 de julio de 2014

National Guideline Clearinghouse | BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.

full-text ►

National Guideline Clearinghouse | BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.


British Committee for Standards in Haematology
National Guideline Clearinghouse (NGC)


Guideline Title

BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.

Bibliographic Source(s)
Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014 Feb;24(1):8-20. [47 references]

Guideline Status

This is the current release of the guideline.
This guideline updates a previous version: Parker J, Wray J, Gooch A, Robson S, Qureshi H. Guidelines for the use of prophylactic anti-D immunoglobulin. London (UK): British Committee for Standards in Haematology (BCSH); 2006. 13 p. [21 references]

No hay comentarios:

Publicar un comentario